Free-cash-flow proxy decreased 16.6%
Free-cash-flow proxy changed -16.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$235.5M→$196.4M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →MEDP financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents increased 147.2%
Cash & equivalents changed +147.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$285.4M→$705.3M4 prior comparisons
Working capital / assets moved 2028 bp higher
Working capital / assets changed +2028 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
-31.18%→-10.90%4 prior comparisons
Current assets increased 68.9%
Current assets changed +68.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$737.3M→$1.2B4 prior comparisons
Working capital increased 54.1%
Working capital changed +54.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
-$546.6M→-$251.1M4 prior comparisons
Operating income increased 16.7%
Operating income changed +16.7% from the comparable as-filed period.
$141.8M→$165.5M2 prior comparisons
Capital expenditure increased 88.2%
Capital expenditure changed +88.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$10.7M→$20.2M2 prior comparisons
Current ratio increased 71.5%
Current ratio changed +71.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
0.43→0.734 prior comparisons
Working capital / assets moved 2579 bp higher
Working capital / assets changed +2579 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
-44.52%→-18.72%4 prior comparisons
Cash & equivalents changed across a low base
Cash & equivalents changed +985.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a low base.
$46.3M→$502.7M4 prior comparisons
Capital expenditure increased 291.2%
Capital expenditure changed +291.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$6.1M→$23.9M3 prior comparisons
Working capital increased 45.0%
Working capital changed +45.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
-$699.6M→-$385.1M4 prior comparisons
Revenue increased 17.2%
Revenue changed +17.2% from the comparable as-filed period.
$603.3M→$707.3M2 prior comparisons
Capex / revenue moved 237 bp higher
Capex / revenue changed +237 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
1.01%→3.38%2 prior comparisons
Operating income increased 16.2%
Operating income changed +16.2% from the comparable as-filed period.
$126.3M→$146.8M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.